Fused heterocylic compounds and their use as mgGlur5 modulators

Details for Australian Patent Application No. 2007248292 (hide)

International Classifications

Event Publications

6 November 2008 PCT application entered the National Phase

PCT publication WO2007/130824 Priority application(s): WO2007/130824

4 December 2008 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name AstraZeneca AB, Application No. 2007248292, under INID(54) correct the title to read Fused heterocylic compounds and their use as mGluR5 modulators

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.